Delivery Order SPE2DX22D0010-SPE2D825FCN66
Award Date
1/9/25
Potential Completion Date
1/10/25
Potential Value
$4.4K
Federal Agency
Medical Supply Chain
Awardee
Amerisourcebergen Drug Corp
Ultimate Awardee
Not listed
NAICS Category
325411 - Medicinal and Botanical Manufacturing
PSC Category
6505 - Drugs And Biologicals
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
This federal contract award, valued at $6,275.14, was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor. The contract is for the delivery of 4,565,698,799 hydromorphone HCL ER 16 mg tablets in 100-count bottles. This is a delivery order contract, with a firm fixed price pricing type, and no set-aside designation. The period of performance runs from the award date of September 5, 2024 through September 6, 2024.
Amerisourcebergen is...
This is a federal delivery order contract awarded by the Defense Logistics Agency (DLA) Troop Support Medical to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the delivery of 12mg hydromorphone hydrochloride extended-release tablets, with a ceiling value of $5,123.41 and a period of performance through October 24, 2024.
AmerisourceBergen holds a $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support...
This is a delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor. The contract, valued at $1,030.82, is for the delivery of hydromorphone 1 mg/ml vials. The contract has a completion date of March 5, 2024 and is a firm fixed-price arrangement. This order is part of a larger Indefinite Delivery Contract (IDC) that AmerisourceBergen holds with the DLA Troop Support Medical, valued at $999,999,999 and running...
This is a federal contract award from the Defense Logistics Agency (DLA) Troop Support Medical to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $2,927.70, is a Delivery Order for 32mg Hydromorphone HCl Extended Release Tablets. The contract has an ultimate completion date of January 7, 2025 and is a Firm Fixed Price contract. AmerisourceBergen holds a $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop...
This federal contract award was made by the Defense Logistics Agency (DLA) to the prime contractor Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $3,533.93 firm fixed-price delivery order covers the supply of 0.5 mg/0.5 ml hydromorphone medication to support military healthcare programs. The contract has an ultimate completion date of December 27, 2024 and was awarded on December 26, 2024. This contract award is part of a larger...
This federal contract award to AmerisourceBergen Drug Corp, a subsidiary of AmerisourceBergen Corporation, is a firm fixed price delivery order from the Defense Logistics Agency (DLA) Troop Support Medical valued at $2,184.76. The award is for the supply of 4,564,222,202 units of Hydromorphone HCL ER 8 mg tablets in 100-count bottles. This delivery order is part of a larger indefinite delivery contract (IDC) valued up to $999,999,999.00 that AmerisourceBergen Drug Corp holds with DLA, which...
This is a federal contract award from the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corporation, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $2,143.85, is for the delivery of 100 tablets of 8 mg hydromorphone hydrochloride extended-release. It is a firm fixed-price delivery order contract with an ultimate completion date of January 8, 2025. The contract is not designated as a set-aside.
AmerisourceBergen holds a significant...
This is a delivery order awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor, for the supply of 100 counts of 8 mg Hydromorphone Hydrochloride Extended Release tablets. The contract has a firm fixed price of $2,512.23 and a completion date of August 9, 2024. The award is not designated as a set-aside contract. This delivery order is part of a larger Indefinite Delivery Contract (IDC) between AmerisourceBergen and the DLA Troop...
This federal contract award with ID SPE2DX15D3020|SPE2DX25FPYGW was issued by the Defense Logistics Agency (DLA) Troop Support Medical to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $3,128.90 Firm Fixed Price delivery order is for the supply of 100 tablets of Hydromorphone HCL ER 16 mg. This award is part of a larger Indefinite Delivery Contract (IDC) valued at $999,999,999 held by Amerisourcebergen with the DLA Troop Support Medical,...
This is a firm fixed price delivery order awarded by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a subsidiary of Amerisourcebergen Corporation, a leading global pharmaceutical sourcing and distribution company. The award, valued at $4,010.30, is for the supply of hydromorphone hydrochloride extended-release 16 mg tablets in quantities of 100.
The delivery order was issued under an indefinite delivery contract (IDC) previously awarded to Amerisourcebergen Drug Corp by...